All Posts

Sparks Sign Multi-Year Community Partnership With Anthem Blue Cross to Address Health Inequities and Social Justice

The Los Angeles Sparks and Anthem Blue Cross announced today a multi-year partnership aimed at serving under-resourced communities through social justice initiatives, health and wellness activations, and athlete advocacy. The New York Liberty, Indiana Fever, and Atlanta Dream are also partnering with Anthem’s sister companies to make a positive impact in their respective cities. Founded in 1996, the Los Angeles Sparks are…

Aspira Women’s Health Appoints Nicole Sandford to its Board of Directors

Aspira Women’s Health, a bioanalytical-based women’s health company, today announced the appointment of Nicole Sandford to its Board of Directors. The company is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management, and improve gynecologic health outcomes for women. “I am very pleased to warmly welcome Nicole…

Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market

Hologic, a global leader in women’s health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics for approximately $230M. Biotheranostics develops and markets two highly differentiated molecular diagnostic tests for breast and metastatic cancers. “We are very pleased to complete the acquisition of Biotheranostics and look forward to working with our new colleagues to grow in the large, rapidly expanding oncology space,”…

Ovia Health Joins the Digital Therapeutics Alliance as First Maternal Health Company

Ovia Health, a digital family health solution, is joining the Digital Therapeutics Alliance (DTA), a global non-profit organization with the mission of advancing digital therapeutics into healthcare. Ovia is the first maternal and family health company to join the Alliance. Since 2012, Ovia Health has helped more than 15 million people successfully navigate their parenthood journeys and is on a mission to make a…

Building and Monetizing Communities in Women’s Health

It’s been all over twitter these past couple of weeks: Community is the new moat and has founders and investors equally excited. Community has made its way back into pitch decks as a strategic advantage and the digital health space is no exception here. But what does all of this mean for women’s health startups and how does one build, scale and…

Nike and ABOUT YOU Launch a Co-Branded Campaign Addressing the Power of the Menstrual Cycle

The menstrual cycle is still a taboo topic in public discourse. Nike and ABOUT YOU have taken this as an opportunity to address the relevant topic of the menstrual cycle in their jointly developed campaign for the launch of the new Nike SuperRep training shoe in Germany. Goal of the campaign is to motivate women to find out about their menstrual cycle…

ExEm Foam, the Only FDA-Approved Contrast Agent for Ultrasound Tubal Patency Testing Is Now Available in the U.S.

ExEm Foam Inc announced today that ExEm Foam (air polymer-type A intrauterine foam), the only FDA-approved contrast agent for ultrasound tubal patency testing, is now available at select fertility clinics in the U.S.. The Foam procedure, a new ultrasound technique of hysterosalpingo foam sonography (HyFoSy), uses ExEm Foam to assess whether there may be a blockage in the fallopian tubes in women…

A New Report Makes the Case for Investing in Menstrual Health

Last month, Population Services International (PSI), PSI-Europe, The Case for Her, WASH United, and Simavi, in collaboration with the Global Menstrual Collective, launched a groundbreaking report, Making the Case for Investing in Menstrual Health & Hygiene. Despite the far ranging impacts good menstrual health & hygiene (MHH) can have for women, girls, and all people who menstruate, roughly 500 million menstruators face limitations when it comes to managing their…